Jul 11, 2022
13:10
For every 10 shares held, investors received 13. The price per share adjusted from $28.45 to $21.88.
The split itself did not change the total investment value.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A (SSE:603707) operates in the Pharmaceuticals: major industry.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A company overviewNanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A's most recent stock split was on July 11, 2022. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A (SSE:603707) has split its stock 5 times: a 13-for-10 split on April 3, 2018, a 13-for-10 split on July 10, 2019, a 13-for-10 split on July 23, 2020, a 13-for-10 split on July 15, 2021, and a 13-for-10 split on July 11, 2022.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A has split its stock 5 times. This history records 5 forward splits between April 3, 2018 and July 11, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A's 13-for-10 split on July 11, 2022, every 10 shares became 13 shares.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on July 11, 2022, 4 years ago. Companies announce splits in advance, and any new SSE:603707 split will appear on this page.
Already premium?